News
Mission drives innovation, and innovation improves quality of life
News
TargetRx Completes Series C Financing
2025-01-22 Views:
Shenzhen TargetRx, Inc. announced today that it has successfully completed its Series C financing, raising $50 million. The funds will be used to advance the overseas clinical development of multiple innovative drugs.
Prev: AACR 2025 | TargetRx Reveals First Preclinical Data on Two Novel, Oral Potent Protein Degraders
Tel: +86-0755-86934300
3rd Floor, Building A1, Kexing Science Park, No. 15 Keyuan Rd., Nanshan District, Shenzhen, China
E-mail: 